Related Experiment Videos
Celastrol alleviates synovial inflammation and joint destruction in rheumatoid arthritis in association with
Yunke Guo1,2, Hao Tang3, Aydana Musha1
1Department of Rheumatism, Traditional Chinese Medicine Hospital of Ili Kazakh Autonomous Prefecture, No.2, Health Street, Economic Cooperation Zone, Ili, 835000, Xinjiang, China.
Abstract:
Rheumatoid arthritis (RA) is characterized by persistent synovial inflammation, oxidative imbalance, and progressive joint destruction. Celastrol (CEL), a bioactive triterpenoid derived from Tripterygium wilfordii, exhibits anti-inflammatory and antioxidant activities, but its mechanism of action in RA remains incompletely defined. This study investigated whether the Nrf2/HO-1/GPX4 pathway is involved in the protective effects of CEL in RA. Collagen-induced arthritis (CIA) rats were treated with CEL or methotrexate for 4 weeks. Arthritis severity, serum inflammatory cytokines, histopathological injury, oxidative stress, and pathway-related proteins were evaluated. In vitro, TNF-α-stimulated fibroblast-like synoviocytes (FLS) were used to assess proliferation, migration, invasion, apoptosis, inflammatory responses, and ROS/Fe²⁺ accumulation. tBHQ and Brusatol were used as pharmacological pathway-modulating probes in functional and rescue experiments. CEL significantly reduced paw swelling, arthritis scores, and serum IL-1β, IL-6, and TNF-α levels in CIA rats, and attenuated synovial hyperplasia, cartilage damage, collagen loss, and osteoclast activation. CEL also increased Nrf2, HO-1, and GPX4 expression while reducing ROS and Fe2+ accumulation in ankle-joint-derived single-cell suspensions. In TNF-α-stimulated rat FLS, CEL suppressed proliferation, migration, and invasion, increased apoptosis under inflammatory stimulation, and alleviated inflammatory and oxidative stress responses. These protective effects were pharmacologically enhanced by tBHQ and attenuated by Brusatol co-treatment. These findings suggest that CEL alleviates synovial inflammation and joint injury in experimental RA in association with Nrf2/HO-1/GPX4 pathway activation and suppression of TNF-α-stimulated rat FLS activation, supporting further investigation of CEL as a candidate antioxidant-oriented therapeutic agent for RA.
Related Concept Videos
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
The JAK-STAT Signaling Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
TGF - β Signaling Pathway
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...